0001179110-20-000468.txt : 20200110
0001179110-20-000468.hdr.sgml : 20200110
20200110160500
ACCESSION NUMBER: 0001179110-20-000468
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200109
FILED AS OF DATE: 20200110
DATE AS OF CHANGE: 20200110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROBERTSON MICHELLE
CENTRAL INDEX KEY: 0001755098
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37687
FILM NUMBER: 20521105
MAIL ADDRESS:
STREET 1: C/O MOMENTA PHARMACEUTICALS, INC.
STREET 2: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Editas Medicine, Inc.
CENTRAL INDEX KEY: 0001650664
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 464097528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11 HURLEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-401-9000
MAIL ADDRESS:
STREET 1: 11 HURLEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
edgar.xml
FORM 4 -
X0306
4
2020-01-09
0
0001650664
Editas Medicine, Inc.
EDIT
0001755098
ROBERTSON MICHELLE
C/O EDITAS MEDICINE, INC.
11 HURLEY ST.
CAMBRIDGE
MA
02141
0
1
0
0
Chief Financial Officer
Common Stock
2020-01-09
4
A
0
20000
0
A
20000
D
Stock Option (right to buy)
30.65
2020-01-09
4
A
0
120000
0
A
2030-01-08
Common Stock
120000
120000
D
The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on January 9, 2021 continuing through January 9, 2024.
This option was granted on January 9, 2020 and is scheduled to vest over four years, with 25% of the shares to vest on January 9, 2021 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through January 9, 2024.
/s/ Michelle Robertson
2020-01-10